CRYPTOMAP
Live / Registered — Registered (as of 19 Aug 2025)
What this means for you
Registered since 19 Aug 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98748841
- Registration number
- 7898128
- Mark type
- Stylized text
- Filed
- 13 Sept 2024
- Published for opposition
- 03 Jun 2025
- Registered
- 19 Aug 2025
- Attorney of record
- Scott D. Locke
Goods and services
- Class 001 — Chemicals: Active chemical ingredients for use in the manufacture of anti-cancer therapeutics and vaccines; chemicals, reagents and substances, being diagnostic reagents, buffers, nucleic acids, peptides, antibodies and immunological peptides for medical research; antibodies for scientific purposes; immunoassay reagents, other than for medical or veterinary use; diagnostic preparations and reagents for scientific or research use; test kits for scientific or research use composed primarily of nucleic acids, peptides, antibodies, buffers and reagents; proteins, namely, monoclonal and polyclonal antibodies, and immunological peptides for scientific or research use; nucleotides for scientific and research use
- Class 005 — Pharmaceuticals: Pharmaceutical products and preparations for the treatment of cancer; pharmaceutical products and preparations for the prevention of cancer; vaccines; tumor antigens for medical use; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for regulating the immune system; immunoassay reagents for medical use; proteins with diagnostic and therapeutic uses, namely, protein arrays for medical diagnosis purposes; diagnostic reagents for medical use; diagnostic and testing preparations for clinical, medical and medical laboratory use, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in oncology and immunology testing for medical purposes; diagnostic test kits for medical purposes, namely, diagnostic kits comprising diagnostic agents, preparations and substances for medical use; antibodies for medical purposes; antigens for medical use; viral antigens for medical use; endogenous antigens for medical use; exogenous antigens for medical use
- Class 042 — Scientific and technological services: Research and development in the fields of medicine in the nature of oncology and immunology; scientific research for medical purposes in the field of oncology; mining in the field of biology; biological research services; pharmaceutical research services; analysis of human tissues for medical research; drug discovery services; provision of information and data on oncology and immunology; biomedical research services conducted using databases; consultancy, information and advisory services in the fields of oncology and immunology
- Class 044 — Medical, beauty and agricultural services: Services in the field of oncology and immunology, namely, medical analysis services for the diagnosis of cancer and immunological disorders; medical screening services in the fields of oncology and immunology.
Owner
- Epitopea Ltd., Cambridge, GB
- Epitopea Ltd., Cambridge, GB
- Epitopea Ltd., Cambridge, GB
- Epitopea Inc., Montreal, Quebec, CA
- Epitopea Inc., Montreal, Quebec, CA
- Epitopea Inc., Montreal, Quebec, CA
Prosecution history
- 19 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 19 Aug 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Jun 2025 — PUBLISHED FOR OPPOSITION
- 28 May 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 May 2025 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 25 Apr 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Apr 2025 — EXAMINER'S AMENDMENT ENTERED
- 25 Apr 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 25 Apr 2025 — EXAMINERS AMENDMENT E-MAILED
- 25 Apr 2025 — EXAMINERS AMENDMENT -WRITTEN
- 25 Apr 2025 — EXAMINER'S AMENDMENT ENTERED
- 25 Apr 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 25 Apr 2025 — EXAMINERS AMENDMENT E-MAILED
- 25 Apr 2025 — EXAMINERS AMENDMENT -WRITTEN